Analysts have been eager to weigh in on the Healthcare sector with new ratings on Bruker (BRKR – Research Report), Canopy Growth (CGC – Research Report) and Medtronic (MDT – Research Report).
Bruker (BRKR)
In a report released yesterday, Derik De Bruin from Bank of America Securities maintained a Buy rating on Bruker, with a price target of $85.00. The company’s shares closed last Tuesday at $76.79.
According to TipRanks.com, Bruin is a 3-star analyst with an average return of
Currently, the analyst consensus on Bruker is a Moderate Buy with an average price target of $80.50, representing a 7.8% upside. In a report released yesterday, J.P. Morgan also upgraded the stock to Buy with a $90.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Canopy Growth (CGC)
Bank of America Securities analyst Lisa Lewandowski reiterated a Sell rating on Canopy Growth yesterday and set a price target of $2.97. The company’s shares closed last Tuesday at $3.49, close to its 52-week low of $3.41.
Lewandowski has an average return of
According to TipRanks.com, Lewandowski is ranked #1167 out of 8716 analysts.
Currently, the analyst consensus on Canopy Growth is a Moderate Sell with an average price target of $3.19, a -14.9% downside from current levels. In a report issued on February 12, Piper Sandler also reiterated a Sell rating on the stock with a $3.00 price target.
Medtronic (MDT)
Bank of America Securities analyst Travis Steed maintained a Buy rating on Medtronic yesterday and set a price target of $100.00. The company’s shares closed last Tuesday at $83.59.
According to TipRanks.com, Steed is a 4-star analyst with an average return of
Medtronic has an analyst consensus of Moderate Buy, with a price target consensus of $90.25, representing a 6.7% upside. In a report released yesterday, TD Cowen also reiterated a Buy rating on the stock with a $90.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on BRKR:
- Bruker Corp Announces Senior Notes Issuance for Corporate Financing
- Bruker Corp Secures CHF 100M in Senior Notes for Growth and Refinancing
- Bruker Corp Announces Private Offering and Financial Strategy
- Bruker announces the acquisition of Japan-based Nanophoton, no terms
- Bruker acquires Spectral Instruments Imaging
